Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The septin cytoskeleton is a regulator of intestinal epithelial barrier integrity and mucosal inflammation
Nayden G. Naydenov, Gaizun Hu, Dominik Robak, Atif Zafar, Khosiyat Makhmudova, Susana Lechuga, Yuta Ohno, Naseer Sangwan, Saikat Bandyopadhyay, Ryan Musich, Erin Jeffery, Lei Sun, Armando Marino-Melendez, Florian Rieder, Gloria Sheynkman, Andrei I. Ivanov, Seham Ebrahim
Nayden G. Naydenov, Gaizun Hu, Dominik Robak, Atif Zafar, Khosiyat Makhmudova, Susana Lechuga, Yuta Ohno, Naseer Sangwan, Saikat Bandyopadhyay, Ryan Musich, Erin Jeffery, Lei Sun, Armando Marino-Melendez, Florian Rieder, Gloria Sheynkman, Andrei I. Ivanov, Seham Ebrahim
View: Text | PDF
Research Article Cell biology Gastroenterology

The septin cytoskeleton is a regulator of intestinal epithelial barrier integrity and mucosal inflammation

  • Text
  • PDF
Abstract

Intestinal epithelial barrier integrity is essential for human health, and its disruption induces and exacerbates intestinal inflammatory disorders. While the epithelial cytoskeleton is critical for maintaining gut barrier-integrity, the role of septins — a family of GTP-binding, cytoskeletal proteins — is largely unknown. This highlights an important knowledge gap, as dysfunction of septins, and specifically septin 9 (SEPT9), is associated with intestinal pathologies. We determined that SEPT9 localizes to the apical junctions of intestinal epithelial cells (IECs), overlapping with both tight and adherens junctions. IEC-specific ablation of SEPT9 in mice resulted in leaky gut, due to mislocalization of junctional proteins, and increased susceptibility to experimental colitis. Consistently, SEPT9 expression was significantly reduced in intestinal mucosa of patients with inflammatory bowel disease (IBD). Using affinity-purification mass spectrometry, super-resolution imaging, and genetic KO, we determined that SEPT9 interacts with and is necessary to recruit nonmuscle myosin IIC (NMIIC) to the IEC perijunctional actomyosin belt. Loss of NMIIC also caused IEC barrier disruption. In summary, SEPT9 regulates intestinal barrier integrity by supporting the assembly of tight and adherens junctions through NMIIC recruitment to the actomyosin belt. The septin cytoskeleton safeguards the intestinal mucosa during acute inflammation, and its disruption in IBD suggests a loss of this protective function.

Authors

Nayden G. Naydenov, Gaizun Hu, Dominik Robak, Atif Zafar, Khosiyat Makhmudova, Susana Lechuga, Yuta Ohno, Naseer Sangwan, Saikat Bandyopadhyay, Ryan Musich, Erin Jeffery, Lei Sun, Armando Marino-Melendez, Florian Rieder, Gloria Sheynkman, Andrei I. Ivanov, Seham Ebrahim

×

Figure 2

SEPT9 is downregulated and mislocalized from epithelial junctions in intestinal mucosa of patients with IBD.

Options: View larger image (or click on image) Download as PowerPoint
SEPT9 is downregulated and mislocalized from epithelial junctions in int...
(A) Confocal images of human colonic mucosa from patients classified as healthy controls (Normal) or those with Crohn’s disease (CD) or ulcerative colitis (UC) immunolabeled for SEPT9 (green) and E-cadherin (red). In control samples, SEPT9 is prominently localized at apical junctions (arrows). In CD tissues, SEPT9 is mislocalized to the cytoplasm (arrowheads). Scale bar: 50 μm. (B) Quantification of mean fluorescence intensity (FI) of SEPT9 immunolabeling in normal and CD ileal and colonic tissue samples and UC colonic samples (n = 7–8 patients/group). (C) Quantification of junctional/cytoplasmic SEPT9 signal ratio across conditions (n = 7–8 patients/group). (D) Representative IHC images (10× and 40×) showing SEPT9 protein localization in colonic tissue of control and patients with IBD. Red arrowheads indicate SEPT9 signal in IECs. Dashed boxes in 10× panels denote regions shown at higher magnification. Scale bars: 50 μm (10×), 10 μm (40×). (E) Quantification of SEPT9+ epithelial area from IHC sections, showing decreased SEPT9 expression in CD and UC tissues (n = 5–9 patients/group). Data in B, C, and E are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by 1-way ANOVA with Tukey’s multiple-comparison test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts